• Generic Name: polyethylene glycol 3350 and electrolytes oral solution
  • Brand Name: GoLytely
Last updated on MDtodate: 10/6/2022


The following clinically significant adverse reactions are described elsewhere in the labeling:

  • Renal impairment
  • Colonic mucosal ulcerations and ischemic colitis
  • Patients with significant gastrointestinal disease
  • Aspiration

The following adverse reactions associated with the use of GoLYTELY were identified in clinical trials or postmarketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency, reliably, or establish a causal relationship to drug exposure.

  • Cardiovascular: arrhythmia, atrial fibrillation, peripheral edema, asystole, and acute pulmonary edema after aspiration .
  • Nervous system: tremor, seizure.
  • Hypersensitivity: Urticaria/rash, pruritus, dermatitis, rhinorrhea, dyspnea, chest and throat tightness, fever, angioedema, anaphylaxis and anaphylactic shock.
  • Gastrointestinal: Nausea, abdominal fullness and bloating are the most common adverse reactions (occurred in up to 50% of patients). Other less common adverse reactions include: abdominal cramps, vomiting, “butterfly-like” infiltrates on chest X-ray after vomiting and aspirating PEG, anal irritation, and upper GI bleeding from Mallory-Weiss Tear, esophageal perforation [usually with gastroesophageal reflux disease (GERD).